Taiwan

Guerbet- Vectorio

Medtronic- Pipeline Flex Embolization Device

Australia

Medtronic- Pipeline Flex Embolization Device

COOK Medical- Chemoembolization products

Hong Kong

Guerbet- Vectorio

Medtronic- Pipeline Flex Embolization Device

Japan

Terumo Corporation-Embolic Coil

Tokai Medical Products, Inc- Embolic Protection Balloon

Kaneka Corporation- Embolization Coil

Medtronic- Pipeline Flex Embolization Device

Shape Memory medical Inc.,-Medical devices for embolization

COSMOTEC CO.LTD- IMPEDE embolization plugs

Boston Scientific-Embolization products

1. Expert should have at least 10 years of experience in business development or similar function (has
been part of an in-licensing deal), with visibility on industry-wide trends.

2. Has actively participated in an in-licensing deal for one of the Part B companies in past 5 years

Dear ,  

Thank you for responding to me. I'm delighted to have you on board. 

Can you please take out 2 minutes to answer these screening questions so we can take the process
forward immediately.    

1) how many years of experience do you have in business development being involved in in-licensing
deals with visibility of industry-wide trends?  

2) Have you actively participated in an in-licensing deal in the past 5 years. Please specify the names of
companies in which you have been the part of drug licensing deals.

3) Do you have any experience with Early stage Pharma drug licensing deals?

4) Please advise your availability for this week and time slot according to your convenience so we can
schedule the zoom meeting.    

Looking forward to your kind response.

Regards,

Ramna

Dear Nobuaki,

Hope you are well and having a great day. This is Ramna from Green Minds - an advisory firm. I’m
reaching out to you on the behalf of my client to engage you in a 60-minute compensated
consultation.

The discussion revolves around understanding the key success factors involved in a drug licensing
deal such as risk assessments, key criteria, and factors influencing a licensing deal, and those factors
drive the value of the licensing deal. In particular, they are interested in speaking with someone who
is/was being involved in an out-licensing/in-licensing deals and can discuss the process of execution
and what happens post entering into such deals. Furthermore, they would like to hear your
perspective and viewpoint on a new development in this domain.

Considering your strong experience I am affirmative that you would be the best fit for this study. If
interested let me know so we can take the process forward. We understand that your time is valuable
and we’ll be happy to compensate you with an honorarium of $250 USD/hr. Hoping to hear from
you soon. Take care.
Christoph Beglinger